These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

330 related items for PubMed ID: 18070865

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Olanzapine versus aripiprazole for the treatment of agitation in acutely ill patients with schizophrenia.
    Kinon BJ, Stauffer VL, Kollack-Walker S, Chen L, Sniadecki J.
    J Clin Psychopharmacol; 2008 Dec; 28(6):601-7. PubMed ID: 19011427
    [Abstract] [Full Text] [Related]

  • 3. Intramuscular aripiprazole for the treatment of acute agitation in patients with schizophrenia or schizoaffective disorder: a double-blind, placebo-controlled comparison with intramuscular haloperidol.
    Andrezina R, Josiassen RC, Marcus RN, Oren DA, Manos G, Stock E, Carson WH, Iwamoto T.
    Psychopharmacology (Berl); 2006 Oct; 188(3):281-92. PubMed ID: 16953381
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Worsened agitation with aripiprazole: adverse effect of dopamine partial agonism?
    DeQuardo JR.
    J Clin Psychiatry; 2004 Jan; 65(1):132-3. PubMed ID: 14976671
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Intramuscular aripiprazole or haloperidol and transition to oral therapy in patients with agitation associated with schizophrenia: sub-analysis of a double-blind study.
    Andrezina R, Marcus RN, Oren DA, Manos G, Stock E, Carson WH, McQuade RD.
    Curr Med Res Opin; 2006 Nov; 22(11):2209-19. PubMed ID: 17076982
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Cochrane for clinicians. Aripiprazole vs. other atypical antipsychotics for schizophrenia.
    Guirguis-Blake J.
    Am Fam Physician; 2010 Jun 01; 81(11):1335-6. PubMed ID: 20521753
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Aripiprazole and adolescent schizophrenia: a simple neuroleptic. No comparison with standard neuroleptic in adolescents.
    Prescrire Int; 2009 Dec 01; 18(104):251. PubMed ID: 20025091
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Switching antipsychotic medications: not enough, too often, or just right?
    Weiden PJ.
    Am J Psychiatry; 2011 Sep 01; 168(9):882-4. PubMed ID: 21890800
    [No Abstract] [Full Text] [Related]

  • 18. Changes in positive and negative syndrome scale-derived hostility factor in adolescents with schizophrenia treated with aripiprazole: post hoc analysis of randomized clinical trial data.
    Robb AS, Carson WH, Nyilas M, Ali M, Forbes RA, Iwamoto T, Assunção-Talbott S, Whitehead R, Pikalov A.
    J Child Adolesc Psychopharmacol; 2010 Feb 01; 20(1):33-8. PubMed ID: 20166794
    [Abstract] [Full Text] [Related]

  • 19. Who responds to aripiprazole in clinical practice? An observational study of combination versus monotherapy.
    Shajahan P, Macrae A, Bashir M, Taylor M.
    J Psychopharmacol; 2008 Sep 01; 22(7):778-83. PubMed ID: 18308790
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.